CAD 15.8
(-1.56%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 112.89 Million CAD | 18.85% |
2022 | 106.1 Million CAD | -22.31% |
2021 | 114.24 Million CAD | 14.4% |
2020 | 83.19 Million CAD | -28.17% |
2019 | 129.8 Million CAD | 1.21% |
2018 | 122.17 Million CAD | 32.24% |
2017 | 95.66 Million CAD | 20.93% |
2016 | 71.51 Million CAD | 17.64% |
2015 | 67.13 Million CAD | 54.87% |
2014 | 47.5 Million CAD | -10.93% |
2013 | 41.83 Million CAD | 22.01% |
2012 | 39.68 Million CAD | 22.55% |
2011 | 31.19 Million CAD | -22.4% |
2010 | 27.08 Million CAD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 52.38 Million CAD | 104.94% |
2024 Q2 | 34.59 Million CAD | -36.75% |
2023 Q2 | 26.3 Million CAD | 10.2% |
2023 Q3 | 25.72 Million CAD | -2.22% |
2023 Q4 | 25.57 Million CAD | -0.57% |
2023 Q1 | 23.87 Million CAD | 13.42% |
2023 FY | - CAD | 18.85% |
2022 Q2 | 17.68 Million CAD | -26.06% |
2022 Q3 | 22.72 Million CAD | 28.45% |
2022 Q4 | 21.04 Million CAD | -7.38% |
2022 Q1 | 23.92 Million CAD | -6.66% |
2022 FY | - CAD | -22.31% |
2021 Q3 | 25.97 Million CAD | 15.61% |
2021 Q1 | 35.81 Million CAD | 62.56% |
2021 FY | - CAD | 14.4% |
2021 Q2 | 22.46 Million CAD | -37.27% |
2021 Q4 | 25.63 Million CAD | -1.32% |
2020 Q4 | 22.03 Million CAD | 15.23% |
2020 FY | - CAD | -28.17% |
2020 Q1 | 34.08 Million CAD | 8.26% |
2020 Q2 | 20.82 Million CAD | -38.9% |
2020 Q3 | 19.12 Million CAD | -8.17% |
2019 Q3 | 34.51 Million CAD | 0.78% |
2019 Q1 | 33.49 Million CAD | -0.41% |
2019 Q2 | 34.25 Million CAD | 2.26% |
2019 FY | - CAD | 1.21% |
2019 Q4 | 31.48 Million CAD | -8.79% |
2018 Q1 | 28.54 Million CAD | 7.66% |
2018 Q4 | 33.63 Million CAD | -3.38% |
2018 FY | - CAD | 32.24% |
2018 Q3 | 34.8 Million CAD | -1.0% |
2018 Q2 | 35.15 Million CAD | 23.16% |
2017 Q3 | 25.77 Million CAD | 3.17% |
2017 Q1 | 22.64 Million CAD | -3.78% |
2017 FY | - CAD | 20.93% |
2017 Q4 | 26.51 Million CAD | 2.86% |
2017 Q2 | 24.98 Million CAD | 10.34% |
2016 Q1 | 17.44 Million CAD | -4.24% |
2016 FY | - CAD | 17.64% |
2016 Q4 | 23.53 Million CAD | 2.87% |
2016 Q3 | 22.87 Million CAD | 21.85% |
2016 Q2 | 18.77 Million CAD | 7.65% |
2015 Q4 | 18.21 Million CAD | -2.98% |
2015 FY | - CAD | 54.87% |
2015 Q1 | 16.38 Million CAD | -4.49% |
2015 Q2 | 16.86 Million CAD | 2.96% |
2015 Q3 | 18.77 Million CAD | 11.31% |
2014 Q3 | 17.97 Million CAD | 7.96% |
2014 FY | - CAD | -10.93% |
2014 Q1 | -6.41 Million CAD | -139.21% |
2014 Q4 | 17.15 Million CAD | -4.55% |
2014 Q2 | 16.64 Million CAD | 359.42% |
2013 Q3 | 13.27 Million CAD | 17.28% |
2013 FY | - CAD | 22.01% |
2013 Q2 | 11.31 Million CAD | 13.59% |
2013 Q1 | 9.96 Million CAD | 18.38% |
2013 Q4 | 16.36 Million CAD | 23.29% |
2012 Q3 | 12.4 Million CAD | 6.23% |
2012 Q2 | 11.67 Million CAD | 20.85% |
2012 Q1 | 9.66 Million CAD | -8.54% |
2012 FY | - CAD | 22.55% |
2012 Q4 | 8.41 Million CAD | -32.13% |
2011 Q4 | 10.56 Million CAD | 24.39% |
2011 Q3 | 8.49 Million CAD | -0.02% |
2011 FY | - CAD | -22.4% |
2011 Q2 | 8.49 Million CAD | 9.36% |
2011 Q1 | 7.76 Million CAD | -69.62% |
2010 Q4 | 25.56 Million CAD | 879.95% |
2010 FY | - CAD | 0.0% |
2010 Q2 | 2.53 Million CAD | 0.0% |
2010 Q3 | 2.6 Million CAD | 3.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
CareRx Corporation | 25.95 Million CAD | -334.993% |
dentalcorp Holdings Ltd. | 197.4 Million CAD | 42.807% |
Extendicare Inc. | 98.61 Million CAD | -14.487% |
Numinus Wellness Inc. | -26.66 Million CAD | 523.432% |
WELL Health Technologies Corp. | 101.87 Million CAD | -10.818% |